Thyroid incidentaloma identified by 18F-fluorodeoxyglucose positron emission tomography with CT (FDG-PET/CT): Clinical and pathological relevance

Clinical Endocrinology

Volumn 75, Issue 4, 2011, Pages 528-534

  Pagano, L ^a   Sama M T ^a   Morani, F ^a,b   Prodam, F ^a   Rudoni, M ^c   Boldorini, R ^d   Valente, G ^a   Marzullo, P ^a   Baldelli, R ^e   Appetecchia, M ^e   Isidoro, C ^b   Aimaretti, Gianluca ^a  

^a UNIVERSITY OF EASTERN PIEDMONT   (Italy)

^b Department of Medical Science ^*  (Italy)

^c Nuclear Medicine   (Italy)

^d University of Piemonte Orientale A Avogadro   (Italy)

^e REGINA ELENA NATIONAL CANCER INSTITUTE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

FLUORODEOXYGLUCOSE F 18; DIAGNOSTIC AGENT;

ADULT; AGED; ARTICLE; ASPIRATION BIOPSY; BENIGN TUMOR; BONE BIOPSY; CLINICAL FEATURE; COLOR ULTRASOUND FLOWMETRY; COMPUTER ASSISTED EMISSION TOMOGRAPHY; DRUG UPTAKE; EUTHYROIDISM; FEMALE; HASHIMOTO DISEASE; HISTOPATHOLOGY; HUMAN; HYPERTHYROIDISM; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; THYROID ADENOMA; THYROID FOLLICULAR CARCINOMA; THYROID FUNCTION TEST; THYROID INCIDENTALOMA; THYROID PAPILLARY CARCINOMA; THYROIDECTOMY; COMPUTER ASSISTED TOMOGRAPHY; METHODOLOGY; MIDDLE AGED; POSITRON EMISSION TOMOGRAPHY; RADIOGRAPHY; THYROID TUMOR;

ADULT; AGED; AGED, 80 AND OVER; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; MALE; MIDDLE AGED; POSITRON-EMISSION TOMOGRAPHY; RETROSPECTIVE STUDIES; THYROID NEOPLASMS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 80052547885     PISSN: 03000664     EISSN: 13652265     Source Type: Journal    
DOI: 10.1111/j.1365-2265.2011.04107.x     Document Type: Article

References (23)

1. Tan, G.H., &, Gharib, H., (1997) Thyroid incidentalomas: management approaches to nonpalpable nodules discovered incidentally on thyroid imaging. Annals of Internal Medicine, 126, 226-231. (Pubitemid 27061578)
2. Macapinlac, H.A., (2005) FDG-PET in head and neck, and thyroid cancer. Chang Gung Medical Journal, 28, 284-295.
3. Palmedo, H., Bucerius, J., Joe, A., et al. (2006) Integrated PET/CT in differentiated thyroid cancer: diagnostic accuracy and impact on patient management. Journal of Nuclear Medicine, 47, 616-624. (Pubitemid 46768462)
4. Kang, K.W., Kim, S.K., Kang, H.S., et al. (2003) Prevalence and risk of cancer of focal thyroid incidentaloma identified by 18F-fluorodeoxyglucose positron emission tomography for metastasis evaluation and cancer screening in healthy subjects. Journal of Clinical Endocrinology and Metabolism, 88, 4100-4104. (Pubitemid 37153705)
5. Choi, J.Y., Lee, K.S., Kim, H.J., et al. (2006) Focal thyroid lesions incidentally identified by integrated F18-FDG PET/CT: clinical significance and improved characterization. Journal of Nuclear Medicine, 47, 609-615.
6. Kim, T.Y., Kim, W.B., Ryu, J.S., et al. (2005) F18-FDG uptake in thyroid from PET for evaluation in cancer patients: high prevalence of malignancy in thyroid PET incidentaloma. Laryngoscope, 115, 1074-1078. (Pubitemid 40777005)
7. Cohen, M.S., Arslan, N., Dehdashti, F., et al. (2001) Risk of malignancy in thyroid incidentalomas identified by fluorodeoxyglucose-positron emission tomography. Surgery, 130, 941-946. (Pubitemid 34014558)
8. Leboulleux, S., Schroeder, P.R., Schlumberger, M., et al. (2007) The role of PET in follow-up of patientstreated for differentiated epithelial thyroid cancers. Nature Clinical Practice Endocrinology & Metabolism, 3, 112-121. (Pubitemid 46146964)
9. Robbins, R.J., &, Larson, S.M., (2008) The value of positron emission tomography (PET) in the management of patients with thyroid cancer. Best Practice & Research. Clinical Endocrinology & Metabolism, 22, 1047-1059.
10. Kim, B.H., Min, A.N., Kim, I.J., et al. (2010) Risk stratification and prediction of cancer of focal thyroid fluorodeoxyglucose uptake during cancer evaluation. Annals of Nuclear Medicine, 24, 721-728.
11. King, D., Stack, B.C., Spring, P.M., et al. (2007) Incidence of thyroid carcinoma in fluorodeoxyglucose positron emission tomography-positive thyroid incidentalomas. Otolaryngology Head and Neck Surgery, 137, 400-404. (Pubitemid 47320854)
12. Mandel, S.J., (2004) Diagnostic use of ultrasonography in patients with nodular thyroid disease. Endocrine Practice, 10, 246-252.
13. Gharib, H., Papini, E., Paschke, R., et al. for the AACE/AME/ETA Task Force on Thyroid Nodules (2010) American Association of Clinical Endocrinologist, Associazione Medici Endocrinologi, and European Thyroid Association medical guidelines for clinical practice for the diagnosis and management of thyroid nodules. Journal of Endocrinological Investigation, 33, 1-50.
14. American Thyroid Association (ATA) Guidelines Taskforce on Thyroid Nodules and Differentiated Thyroid Cancer (2009) Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid, 19, 1167-1214. Erratum in: Thyroid 2010, 20, 674-675.
15. Karantanis, D., Bogsrud, T.V., Wiseman, G.A., et al. (2007) Clinical significance of diffusely increased 18F-FDG uptake in the thyroid gland. Journal of Nuclear Medicine, 48, 896-901. (Pubitemid 46909917)
16. Zhai, G., Zhang, M., Xu, H., et al. (2010) The role of 18F-fluorodeoxyglucose positron emission tomography/computed tomography whole body imaging in the evaluation of focal thyroid incidentaloma. Journal of Endocrinological Investigation, 33, 151-155.
17. Liu, Y., (2009) Clinical significance of thyroid uptake on F18-fluorodeoxyglucose positron emission tomography. Annals of Nuclear Medicine, 23, 17-23.
18. Chen, Y.K., Ding, H.J., Chen, K.T., et al. (2005) Prevalence and risk of cancer of focal thyroid incidentaloma identified by 18F-fluorodeoxyglucose positron emission tomography for cancer screening in healthy subjects. Anticancer Research, 25, 1421-1426.
19. Sebastianes, F.M., Cerci, J.J., Zanoni, P.H., et al. (2007) Role of 18F-FDG PET in preoperative assessment of cytopatogically indeterminate thyroid nodules. Journal of Clinical Endocrinology and Metabolism, 92, 4485-4488.
20. Van Den Bruel, A., Maes, A., De Potter, T., et al. (2002) Clinical relevance of thyroid fluorodeoxyglucose-whole body positron emission tomography incidentaloma. Journal of Clinical Endocrinology and Metabolism, 87, 1517-1520. (Pubitemid 34615231)
21. Di Pasquale, M., Rothstein, J.L., &, Palazzo, J.P., (2001) Pathologic features of Hashimoto's associated papillary thyroid carcinoma. Human Pathology, 32, 24-30. (Pubitemid 32150624)
22. Nakamura, S., Okochi, K., Murata, Y., et al. (2009) [18F] Fluorodeoxyglucose-PET/CT differentiation between physiological and pathological accumulations in head and neck. Nuclear medicine Communications, 30, 498-503.
23. 18F-FDG PET reduces unnecessary hemithyroidectomies for thyroid nodules with indeterminate cytologic results. Journal of Nuclear Medicine, 47, 770-775. (Pubitemid 46768439)